Effect of Choto-san, a Kampo medicine, on the cerebral blood flow autoregulation in spontaneously hypertensive rats

被引:12
|
作者
Sugimoto, A
Goto, K
Ishige, A
Komatsu, Y
Miyamoto, K
机构
[1] Tsumura Co, Kampo & Pharmacognosy Labs, Ami, Ibaraki 3001192, Japan
[2] Kanazawa Univ, Sch Med, Dept Hosp Pharm, Kanazawa, Ishikawa 9200934, Japan
[3] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Pharmacol & Pharmaceut, Div Pharm & Hlth Sci, Kanazawa, Ishikawa 9200934, Japan
关键词
Choto-san; cerebral blood flow autoregulation; Uncariae Ramulus et Uncus; nitric oxide; spontaneously hypertensive rat;
D O I
10.1254/jjp.83.135
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To clarify the mechanism of the benefical effect of Choto-san on cerebral circulation in hypertensive patients, the influence of Choto-san on cerebral blood flow (CBF) during hemorrhagic hypotension was evaluated in 10- to 11-month-old spontaneously hypertensive rats. The lower limit of CBF autoregulation, defined as the mean arterial blood pressure at which CBF decreased by 10% of the baseline value, was dose-dependently lowered when Choto-san (0.5 - 2.0 g/kg per day, p.o.) was administered for 14 consecutive days. Uncariae Ramulus ct Uncus (150 mg/kg per day, p.o.), one of the crude drug components of Chore-san, showed an effect equivalent to that of Choto-san. The action of Choto-san (2.0 g/kg per day, p.o.) or Uncariae Ramulus et Uncus on the autoregulatory response of cerebral vessels was eliminated by treatment with N-G-nitro-L-arginine methyl ester (10 mg/kg, i.v.), an inhibitor of nitric oxide synthase. These results suggested that the activation of nitric oxide synthase by Uncariae Ramulus et Uncus contributed to at least part of the improvement in the cerebral circulation caused by Choto-san.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 50 条
  • [1] Effect of Choto-san, a Kampo medicine, on impairment of passive avoidance performance in mice
    Yuzurihara, M
    Goto, K
    Sugimoto, A
    Ishige, A
    Komatsu, Y
    Shimada, Y
    Terasawa, K
    PHYTOTHERAPY RESEARCH, 1999, 13 (03) : 233 - 235
  • [2] Pharmacological evidence for antidementia effect of Choto-san (Gouteng-san), a traditional Kampo medicine
    Watanabe, H
    Zhao, Q
    Matsumoto, K
    Tohda, M
    Murakami, Y
    Zhang, SH
    Kang, TH
    Mahakunakorn, P
    Maruyama, Y
    Sakakibara, I
    Aimi, N
    Takayama, H
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 75 (03) : 635 - 643
  • [3] Effect of Choto-san, a Kampo medicine, on impairment of passive avoidance performance in senescence accelerated mouse (SAM)
    Mizushima, Y
    Kan, S
    Yoshida, S
    Irie, Y
    Urata, Y
    PHYTOTHERAPY RESEARCH, 2003, 17 (05) : 542 - 545
  • [4] Effects of Choto-san on hemorheological factors and vascular function in stroke-prone spontaneously hypertensive rats
    Yang, Q
    Goto, H
    Shimada, Y
    Kita, T
    Shibahara, N
    Terasawa, K
    PHYTOMEDICINE, 2002, 9 (02) : 93 - 98
  • [5] Neuroprotective effect from ischemia and direct free radical scavenging activity of Choto-san (kampo medicine)
    Dohi, K
    Satoh, K
    Ikeda, Y
    Ohtaki, H
    Shioda, S
    Aruga, T
    BRAIN EDEMA XII, 2003, 86 : 123 - 127
  • [6] Choto-san prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats
    Shimada, Y
    Yang, Q
    Yokoyama, K
    Goto, H
    Kasahara, Y
    Sekiya, N
    Hikiami, H
    Terasawa, K
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2003, 31 (01): : 79 - 85
  • [7] Hypercapnic cerebral blood flow in spontaneously hypertensive rats
    Heinert, G
    Casadei, B
    Paterson, DJ
    JOURNAL OF HYPERTENSION, 1998, 16 (10) : 1491 - 1498
  • [8] Influence of the renal endothelin system on the autoregulation of renal blood flow in spontaneously hypertensive rats
    Braun, C
    Lang, C
    Hocher, B
    Gretz, N
    vanderWoude, FJ
    Rohmeiss, P
    KIDNEY & BLOOD PRESSURE RESEARCH, 1997, 20 (01) : 6 - 10
  • [9] Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor
    Murakami, Y
    Zhao, Q
    Harada, K
    Tohda, M
    Watanabe, H
    Matsumoto, K
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 81 (03) : 616 - 625
  • [10] Amlodipine, a Ca2+ channel antagonist, modifies cerebral blood flow autoregulation in hypertensive rats
    Cai, H
    Yao, H
    Ibayashi, S
    Takaba, H
    Fujishima, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : 103 - 106